| The Journal of Antibiotics | |
| Cover: | The Journal of Antibiotics.gif |
| Abbreviation: | J. Antibiot. |
| Nlm: | J Antibiot (Tokyo) |
| Discipline: | Microbiology |
| Editor: | Kuniaki Tatsuta |
| Publisher: | Nature Publishing Group |
| History: | 1948–present |
| Frequency: | Monthly |
| Impact: | 3.3 |
| Impact-Year: | 2022 |
| Issn: | 0021-8820 |
| Eissn: | 1881-1469 |
| Coden: | JANTAJ |
| Oclc: | 01642415 |
| Website: | http://www.nature.com/ja/ |
| Link1: | https://www.nature.com/ja/volumes |
| Link1-Name: | Archive 2005–2020 (vol. 58–73) |
| Link2: | https://www.jstage.jst.go.jp/browse/antibiotics1968/list/-char/en |
| Link2-Name: | Archive 1968–2004 (vol. 21–57) |
The Journal of Antibiotics is a peer-reviewed medical journal published by the Nature Publishing Group for the Japan Antibiotics Research Association.
The journal seeks to endorse studies on antibiotics and associated types of biologically-active substances.
In June 2020, the journal published a pioneer systematic review on ivermectin and COVID-19 by Fatemeh Heiday and Reza Gharebaghi which has become highly cited.[1]
The journal is abstracted and indexed for example in:
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.3.[2]